Topic
45 stories
Microsoft’s Founder and philanthropist Bill Gates urged South Korea to do more to avoid infectious illnesses like COVID-19, emphasising the need for the world to be better prepared for the next pandemic. In a speech to South Korean parliamentarians in Seoul, Gates advocated for greater international collaboration, including attempts to create vaccines effective against a […]
Pfizer Inc agreed to pay $5.4 billion in cash for acquiring Global Blood Therapeutics to bolster its pipeline, as it seeks to capitalise on a boom in income from its COVID-19 vaccination and therapy and to counteract a projected slowdown in Covid-19 product demand as instances reduce. Pfizer said on Monday that it will pay […]
The fast-growing monkeypox outbreak is a global health emergency, according to World Health Organization Director-General Tedros Adhanom Ghebreyesus on Saturday. He stated that the danger of monkeypox, which spreads through close contact and causes flu-like symptoms and pus-filled skin lesions, was moderate internationally, with the exception of Europe, where the WHO has classified the risk […]
The US Food and Drug Administration (FDA) convened a meeting on Wednesday. The purpose of this meeting was to have a better understanding of the future of Covid-19 booster shots in light of the rapid mutation of the virus. Expert advisors at the FDA discussion will evaluate who would be eligible for future booster shots, […]
The multinational pharmaceutical corporation Pfizer has signed a deal worth $5.29 billion to supply 10 million Anti-Covid pills to USA. Paxlovid, the pill manufactured by Pfizer could change the fight against the virus, this pill can be provided by physicians to patients at home after infection. It is a highly effective at-home treatment which could […]
The multinational health care company Baxter to acquire medical technology leader Hillrom for $12.4 billion. Hillrom will bring complementing products and innovative pipeline that will enable Baxter to provide a broader array of medical products and services to patients and clinicians across the world. Both the companies will combine together and accelerate the expansion of […]
The German pharmaceutical company Bayer has announced to acquire Vividion Therapeutics for $2 billion. After the acquisition, Bayer will own full rights to Vividion’s proprietary discovery platform, which comprises three integrated, synergistic components: an integrated data portal, a novel chemoproteomic screening technology, and a proprietary chemistry library. The acquisition of Vividion will strengthen Bayer’s small […]
The Medical technological company CMR Surgical has announced that it has raised £425 million in Series D financing at $3B valuation. The round was led by SoftBank Vision Fund 2ii and co-led by Ally Bridge Group and will support the Company’s mission to make keyhole surgery accessible to more people worldwide. The funds will be […]
The global specialist HIV company ViiV Healthcare has entered a global collaboration and license agreement with Halozyme for ENHANZE. Halozyme’s drug delivery technology provides the opportunity to administer large volume subcutaneous injections that may enable dosing intervals of every three months and up to six months or longer for ViiV’s pipeline of HIV medicines. The […]
The health ministry of UAE has started Sinopharm covid vaccine trial for children below 18 Some members of Abu Dhabi’s ruling family had participated in the trial which administered China’s Sinopharm COVID-19 vaccine to children. The UAE in May approved the Pfizer-BioNTech vaccine for emergency use in children aged 12-15. Dubai, the second-largest member of […]
GlaxoSmithKline and iTeos Therapeutics to co-develop and co-commercialise the treatment for patients with cancer . Currently EOS-448, an anti-TIGIT monoclonal antibody is in phase one development, TIGIT which is a part of the CD226 checkpoint axis, has exhibited potential as a hopeful target for the next generation of immuno-oncology therapies based on compelling preclinical data […]
BioNTech and Pfizer has announced its plans to provide 500 million doses to U.S government at a non profit price. Approximately around 200 million doses in 2021 and 300 million by the first half of 2022. These doses from Pfizer and BioNTech will be donated to low and lower middle income countries including the African […]
